Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
SBBP Strongbridge Biopharma plc daily Stock Chart
SBBP [NASD]
Strongbridge Biopharma plc
Healthcare | Biotechnology | USA
statements
Index- P/E3.26 EPS (ttm)0.94 Insider Own0.40% Shs Outstand57.21M Perf Week-6.69%
Market Cap175.63M Forward P/E- EPS next Y-0.71 Insider Trans0.00% Shs Float45.26M Perf Month0.99%
Income43.60M PEG- EPS next Q-0.26 Inst Own60.70% Short Float0.80% Perf Quarter106.04%
Sales20.60M P/S8.53 EPS this Y120.60% Inst Trans-8.41% Short Ratio0.80 Perf Half Y20.87%
Book/sh1.47 P/B2.09 EPS next Y28.30% ROA30.00% Target Price8.00 Perf Year-35.37%
Cash/sh1.39 P/C2.21 EPS next 5Y- ROE45.80% 52W Range1.43 - 5.69 Perf YTD46.89%
Dividend- P/FCF- EPS past 5Y36.70% ROI23.70% 52W High-49.30% Beta0.79
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin80.80% 52W Low101.75% ATR0.23
Employees106 Current Ratio4.20 Sales Q/Q7.50% Oper. Margin- RSI (14)44.36 Volatility7.85% 7.31%
OptionableYes Debt/Eq0.00 EPS Q/Q41.90% Profit Margin- Rel Volume0.98 Prev Close3.07
ShortableYes LT Debt/Eq0.00 EarningsFeb 25 BMO Payout0.00% Avg Volume453.12K Price2.88
Recom1.40 SMA20-10.67% SMA5010.30% SMA20013.45% Volume222,054 Change-6.03%
Sep-25-19Initiated Evercore ISI Outperform
Sep-24-19Initiated Jefferies Buy $8
Dec-18-18Initiated Laidlaw Buy $11
Dec-06-17Initiated Cantor Fitzgerald Buy $14
Jan-25-17Reiterated H.C. Wainwright Buy $15 → $18
Apr-25-16Initiated H.C. Wainwright Buy $15
Nov-10-15Initiated Stifel Buy $21
Nov-10-15Initiated JMP Securities Mkt Outperform
Feb-25-20 08:55AM  Strongbridge Biopharma (SBBP) Reports Q4 Loss, Tops Revenue Estimates Zacks -6.03%
07:30AM  Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update GlobeNewswire
06:30AM  Strongbridge Biopharma Plc to Host Earnings Call ACCESSWIRE
Feb-19-20 07:30AM  Strongbridge Biopharma plc to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call on February 25, 2020 GlobeNewswire
Jan-30-20 04:30PM  Strongbridge Biopharma plc Announces New Employment Inducement Awards GlobeNewswire -8.25%
Jan-09-20 07:30AM  Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2019 Financial Results and Provides Update on Corporate Priorities GlobeNewswire +6.19%
Dec-16-19 07:35AM  Should You Avoid Strongbridge Biopharma plc (SBBP)? Insider Monkey
Nov-18-19 01:03PM  Bucks County biopharm firm makes more job cuts American City Business Journals -6.96%
07:30AM  Strongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead Independent Director GlobeNewswire
Nov-17-19 09:25AM  Edited Transcript of SBBP earnings conference call or presentation 7-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-12-19 07:30AM  Strongbridge Biopharma plc to Present at Two Upcoming Investor Conferences GlobeNewswire
Nov-07-19 09:05AM  Strongbridge Biopharma (SBBP) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:30AM  Strongbridge Biopharma plc Reports Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Nov-06-19 08:21AM  The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings Benzinga +13.21%
Nov-05-19 03:32PM  Bucks County biopharma firm's CEO departs American City Business Journals -34.30%
06:30AM  Strongbridge Biopharma plc Announces CEO Transition Plan and Provides Preliminary Third Quarter 2019 Financial Results and Corporate Updates GlobeNewswire
Oct-31-19 10:33AM  Strongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-29-19 07:30AM  Strongbridge Biopharma plc to Host Third Quarter 2019 Financial Results Conference Call on November 7, 2019 GlobeNewswire
Oct-23-19 10:33AM  Will Strongbridge Biopharma (SBBP) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-17-19 07:30AM  Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting GlobeNewswire
Sep-25-19 09:04AM  Strongbridge Biopharma plc to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-19-19 07:30AM  Strongbridge Biopharma plc Announces RECORLEV (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & Endocrinology GlobeNewswire
Sep-03-19 07:30AM  Strongbridge Biopharma plc to Present at the H.C. Wainwright 21st Annual Global Investment Conference and the Janney Montgomery Scott Healthcare Conference 2019 GlobeNewswire
Aug-21-19 10:12PM  Edited Transcript of SBBP earnings conference call or presentation 31-Jul-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-13-19 08:45AM  Strongbridge Biopharma Announces Key Leadership Appointments to Support Next Stage of Growth GlobeNewswire
Jul-31-19 09:15AM  Strongbridge Biopharma (SBBP) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:30AM  Strongbridge Biopharma plc Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Jul-24-19 07:30AM  Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31, 2019 GlobeNewswire
Jul-19-19 07:30AM  Strongbridge Biopharma plc Announces New Employment Inducement Awards GlobeNewswire
Jul-11-19 06:40AM  Is Strongbridge Biopharma plc's (NASDAQ:SBBP) ROE Of 43% Impressive? Simply Wall St.
Jul-01-19 07:30AM  Strongbridge Biopharma plc Added to the Russell 3000® and Microcap® Indexes GlobeNewswire +7.99%
Jun-23-19 04:11PM  Heres What Hedge Funds Think About Strongbridge Biopharma plc (SBBP) Insider Monkey
Jun-12-19 07:30AM  Strongbridge Biopharma plc to Present at the 2019 JMP Securities Life Sciences Conference GlobeNewswire +5.00%
Jun-04-19 07:30AM  Strongbridge Biopharma plc Strengthens Senior Leadership Team with Key Promotion and Appointment GlobeNewswire
May-30-19 07:30AM  Strongbridge Biopharma plc to Present at the Jefferies 2019 Global Healthcare Conference GlobeNewswire
May-09-19 04:05PM  Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Academy of Neurology Annual Meeting GlobeNewswire -5.46%
May-06-19 05:24PM  Edited Transcript of SBBP earnings conference call or presentation 1-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-04-19 11:14PM  Edited Transcript of SBBP earnings conference call or presentation 26-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
May-02-19 12:23AM  Strongbridge Biopharma (SBBP) Q1 2019 Earnings Call Transcript Motley Fool
May-01-19 01:16PM  Strongbridge Biopharma (SBBP) Reports Q1 Loss, Lags Revenue Estimates Zacks -20.88%
11:12AM  Strongbridge Biopharma plc (SBBP) Q1 2019 Earnings Call Transcript Motley Fool
07:30AM  Strongbridge Biopharma plc Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Apr-26-19 09:43AM  News Surrounds 3 Small Biotechs, With a Merger Claiming One TheStreet.com
08:02AM  The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug Benzinga
Apr-25-19 04:01PM  Strongbridge Biopharma plc Announces Presentation of New Secondary Endpoint Data from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 2019 American Association of Clinical Endocrinologists Annual Scientific and Clinical Congress GlobeNewswire
Apr-24-19 07:30AM  Strongbridge Biopharma plc to Host First Quarter 2019 Financial Results Conference Call on May 1, 2019 GlobeNewswire
Apr-18-19 10:13AM  Does Strongbridge Biopharma plc's (NASDAQ:SBBP) CEO Pay Compare Well With Peers? Simply Wall St.
Apr-15-19 07:30AM  Strongbridge Biopharma plc Announces Upcoming Presentation of New Data from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 2019 American Association of Clinical Endocrinologists (AACE) Annual Scientific and Clinical Congress GlobeNewswire
Mar-25-19 07:30AM  Strongbridge Biopharma plc Announces Presentation of New Data Analyses from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Potential Treatment of Endogenous Cushings Syndrome GlobeNewswire -6.99%
Mar-11-19 12:36PM  Is Strongbridge Biopharma plc (NASDAQ:SBBP) Potentially Underrated? Simply Wall St. +9.09%
07:30AM  Strongbridge Biopharma plc Announces Top-Line Results from Extended Evaluation Phase of the Pivotal Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Potential Treatment of Endogenous Cushings Syndrome GlobeNewswire
Mar-08-19 07:30AM  Strongbridge Biopharma plc Announces New Employment Inducement Awards GlobeNewswire
Mar-04-19 08:58AM  What's in the Cards for Aeterna (AEZS) This Earnings Season? Zacks
07:30AM  Strongbridge Biopharma plc Announces Upcoming Presentation of New Data from Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 2019 Annual Meeting of the Endocrine Society (ENDO) GlobeNewswire
Feb-27-19 07:30AM  Strongbridge Biopharma plc to Present at the Cowen and Company 39th Annual Healthcare Conference and the Oppenheimer 29th Annual Healthcare Conference GlobeNewswire +5.32%
Feb-26-19 10:44AM  Strongbridge Biopharma plc (SBBP) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:30AM  Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2018 Financial Results GlobeNewswire
Feb-22-19 07:30AM  Strongbridge Biopharma plc Announces Annual General Meeting of Shareholders GlobeNewswire
Feb-19-19 07:30AM  Strongbridge Biopharma plc to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call on February 26, 2019 GlobeNewswire
Jan-31-19 11:21AM  What Kind Of Investor Owns Most Of Strongbridge Biopharma plc (NASDAQ:SBBP)? Simply Wall St.
Jan-23-19 09:19AM  These 2 Biotech Stocks Seem Significantly Undervalued TheStreet.com
Dec-19-18 11:15AM  Strongbridge completes $181.7M sale of hormone drug to Novo Nordisk American City Business Journals
07:30AM  Strongbridge Biopharma plc Announces Closing of Transaction with Novo Nordisk to Transfer the Rights to MACRILEN (macimorelin) in the United States and Canada GlobeNewswire
Dec-18-18 03:05AM  Do Hedge Funds Love Strongbridge Biopharma plc (SBBP)? Insider Monkey
Nov-27-18 08:35AM  Factors of Influence in 2018, Key Indicators and Opportunity within Dillard's, Biohaven Pharmaceutical Holding, HTG Molecular Diagnostics, Strongbridge Biopharma, Myriad Genetics, and Beazer Homes New Research Emphasizes Economic Growth GlobeNewswire
Nov-20-18 07:30AM  Strongbridge Biopharma plc Announces Presentation of New Data Comparing the In Vitro Effects of Levoketoconazole, the Active Ingredient in RECORLEV, and Ketoconazole on Human Cortisol Production GlobeNewswire
Nov-13-18 07:26AM  Edited Transcript of SBBP earnings conference call or presentation 31-Oct-18 1:15pm GMT Thomson Reuters StreetEvents
Nov-05-18 04:15PM  Strongbridge Biopharma plc to Present at the Stifel 2018 Healthcare Conference GlobeNewswire
Nov-01-18 07:50AM  Todays Research Reports on Stocks to Watch: Strongbridge Biopharma and Clovis Oncology ACCESSWIRE -7.50%
Oct-31-18 10:45AM  $181.7M deal: Strongbridge to sell rights to hormone drug to Novo Nordisk American City Business Journals +58.02%
10:10AM  Strongbridge Biopharma (SBBP) Reports Q3 Loss, Misses Revenue Estimates Zacks
08:47AM  Strongbridge Biopharma plc Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
08:45AM  Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN (macimorelin) GlobeNewswire
Oct-22-18 07:30AM  Strongbridge Biopharma plc Presents Detailed Initial Results from Pivotal Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome at the 18th Annual Congress of the European NeuroEndocrine Association GlobeNewswire
Oct-09-18 08:10AM  Detailed Research: Economic Perspectives on MTS, Delek US, Alarm, Strongbridge Biopharma, Myriad Genetics, and Matson What Drives Growth in Today's Competitive Landscape GlobeNewswire
Sep-18-18 07:30AM  Strongbridge Biopharma plc to Participate in Two Upcoming Healthcare Investor Conferences GlobeNewswire
Aug-28-18 07:31AM  Strongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences GlobeNewswire
Aug-22-18 11:50PM  Edited Transcript of SBBP earnings conference call or presentation 8-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-17-18 12:03PM  Nevermind: Bucks County Biopharm firm backtracks on stock sale American City Business Journals
Aug-16-18 09:37AM  The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait Benzinga +6.93%
Aug-15-18 07:12PM  Strongbridge Biopharma plc Announces Termination of Public Offering of Ordinary Shares GlobeNewswire -19.20%
08:48AM  The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue Benzinga
Aug-14-18 04:23PM  Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares GlobeNewswire
Aug-11-18 07:03AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Aug-09-18 04:19PM  Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results GlobeNewswire
Aug-08-18 01:19PM  Here's Why Strongbridge Biopharma Rose as Much as 26.7% Today Motley Fool +31.11%
11:54AM  Pot Stocks & Biotech Stocks Delivering Strong Progress ACCESSWIRE
08:59AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
08:03AM  Strongbridge Biopharma: 2Q Earnings Snapshot Associated Press
08:00AM  Strongbridge Biopharma (SBBP) Reports Q2 Loss, Lags Revenue Estimates Zacks
06:31AM  Strongbridge Biopharma plc Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
06:30AM  Strongbridge Biopharma plc Announces Positive Top-Line Results from the Pivotal Phase 3 SONICS Study of RECORLEV (levoketoconazole) for the Treatment of Endogenous Cushings Syndrome GlobeNewswire
Aug-01-18 08:20AM  Recent Analysis Shows IAC/InterActiveCorp, Mitek, Apollo Investment, Umpqua, Strongbridge Biopharma, and Endurance International Group Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire +5.26%
Jun-06-18 07:30AM  Strongbridge Biopharma plc to Present at the JMP Securities Life Sciences Conference GlobeNewswire
May-31-18 07:30AM  Strongbridge Biopharma plc to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire -7.14%
May-15-18 10:02PM  Edited Transcript of SBBP earnings conference call or presentation 10-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-10-18 07:30AM  Strongbridge Biopharma plc Reports First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-03-18 07:30AM  Strongbridge Biopharma plc Announces New Employment Inducement Awards GlobeNewswire
Apr-26-18 07:30AM  Strongbridge Biopharma plc to Host First Quarter 2018 Financial Results Conference Call on May 10, 2018 GlobeNewswire
Apr-19-18 05:46PM  With A -133.52% Earnings Drop, Is Strongbridge Biopharma plcs (NASDAQ:SBBP) A Concern? Simply Wall St. -5.00%
Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company's commercial products include Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States; and Macrilen, an oral growth hormone secretagogue receptor agonist for use in the diagnosis of patients with adult growth hormone deficiency. Its clinical-stage product candidates are Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trial that is used for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.
open in yahoo | open in reuters | open in google